Inspections, Compliance, Enforcement, and Criminal Investigations
Types of Warning Letters on the FDA Website
- General FDA Warning Letters
- Tobacco Retailer Warning Letters
- Drug Marketing and Advertising Warning Letters (and Untitled Letters to Pharmaceutical Companies)
Topics on this Page:
- Ways to View/Browse Warning Letters
- More Information About Warning Letters Posted Here
- Recently Posted Warning Letters
Ways to View/Browse Warning Letters
- Review the list of recently posted warning letters below.
- Select the year from the list above in which the warning letter was issued, and browse the chronological list of warning letters on the linked page.
To find specific Warning Letters:
- Perform an Advanced Search
- Use any of these "Browse" functions:
To download information about Warning Letters to an Excel document:
Use the Search and Export Warning Letters to Excel function.
- Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter.
- To obtain available additional information on the current status of an issue in a particular warning letter on this site, contact FDA. Requests to FDA for agency records should be sent to: Food and Drug Administration Division of Freedom of Information (HFI-35), 5630 Fishers Lane, Rockville, MD 20857. Instructions for how to submit an FOI request can be found at How to Make a FOIA Request.
|Letter Issue Date||Company Name||Issuing Office||Subject||Close Out Date|
|June 22, 2016||Coastal Meds, LLC.||New Orleans District Office||CGMP/Compounded Drugs/Misbranding||Not Issued *|
|June 21, 2016||Chongqing Lummy Pharmaceutical Co. Ltd.||Center for Drug Evaluation and Research||CGMP/Active Pharmaceutical Ingredient (API)/Finished Pharmaceuticals/Adulterated||Not Issued *|
|June 21, 2016||POPSALOT, LLC||Los Angeles District Office||Food Labeling/Misbranded||Not Issued *|
|June 16, 2016||Shanghai Desano Chemical Pharmaceutical Co., Ltd.||Center for Drug Evaluation and Research||CGMP/Active Pharmaceutical Ingredient (API)/Adulterated||Not Issued *|
|June 02, 2016||General Medical Company||Los Angeles District Office||CGMP/QSR/Medical Devices/Adulterated||Not Issued *|
|May 19, 2016||Jose Giron||Center for Drug Evaluation and Research||Clinical Investigator||Not Issued *|
|April 12, 2016||Spot On Sciences, Inc.||Center for Devices and Radiological Health||Investigational Device Exemptions (IDE)/Premarket Approval Application (PMA)||Not Issued *|
|April 07, 2016||D & E Dairy||Los Angeles District Office||Illegal Drug Residue||Not Issued *|
|February 04, 2016||Eolane Vailhauques||Center for Devices and Radiological Health||CGMP/QSR/Medical Devices/Adulterated||Not Issued *|